BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Retina
,
DNA fingerprint
,
Aspirin
,
rs2476601
,
IL1A
,
T cell receptor signaling pathway
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
SB203580
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
DHRS2
SERPINA3
ID1
MUC4
MAL
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
cytosol
cell periphery
response to organic substance
regulation of nitrogen compound metabolic process
organic cyclic compound binding
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Cervical cancer HeLa cells with siRNA knockdown of SKIIP, treated with osmostressor NaCl
Lung microvascular endothelial cells treated with combinations of SB203580, UM101 and TNFA
Acute monocytic leukemia (AML) THP-1 cells HIV gp120 or LPS stimulated following SB203580 treatment
BJ foreskin fibroblasts (young and senescent) treated or untreated with p28MAPK inhibitor SB203580
Monocyte-derived dendritic cells treated with MEK inhibitor U0126 or p38/MAPK inhibitor SB203580
Explore Curated Studies Results
Literature
Most Relevant Literature
p38 MAPK inhibitor SB203580 enhances anticancer activity of PARP inhibitor olaparib in a synergistic…
SB203580 protects against inflammatory response and lung injury in a mouse model of lipopolysacchari…
β-glucan improves intestinal health of pearl gentian grouper via activation of the p38 mitogen-activ…
Impact of Combination Therapy with Chemical Drugs and Megavoltage X-ray Exposure on Breast Cancer St…
SB203580, a p38MAPK inhibitor, attenuates olfactory dysfunction by inhibiting OSN apoptosis in AR mi…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Study the Expression of Annexin A1 and Its Potential Usage as a Prognostic Marker in Oral Cancer
Immune Cell Response to Stimuli
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ